Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ramucirumab MeSH Descriptor Data 2025


MeSH Heading
Ramucirumab
Tree Number(s)
D12.776.124.486.485.114.224.060.866
D12.776.124.790.651.114.224.060.866
D12.776.377.715.548.114.224.200.866
Unique ID
D000096662
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000096662
Scope Note
A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2).
Entry Term(s)
1121B
Cyramza
IMC 1121B
IMC-1121B
IMC1121B
LY3009806
Pharm Action
Angiogenesis Inhibitors
Registry Numbers
D99YVK4L0X
0
Public MeSH Note
2024; RAMUCIRUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2009-2023
History Note
2024 (2009)
Date Established
2024/01/01
Date of Entry
2023/07/26
Revision Date
2023/05/17
Ramucirumab Preferred
IMC 1121B Narrower
Cyramza Narrower
LY3009806 Narrower
page delivered in 0.151s